Reste-t-il une place pour la chimiothérapie dans les cancers pulmonaires porteurs d'une altération moléculaire addictive? Les arguments du oui

Benjamin Besse

doi:10.1016/s0007-4551(15)31224-8

Reste-t-il une place pour la chimiothérapie dans les cancers pulmonaires porteurs d'une altération moléculaire addictive? Les arguments du oui

Translated title of the contribution: Is chemotherapy still a valid option for oncogene-addicted lung cancer? Yes

Benjamin Besse

Research output: Contribution to journal › Article › peer-review

Abstract

With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments for the use of cytotoxics in presence of a targetable alteration.

Translated title of the contribution	Is chemotherapy still a valid option for oncogene-addicted lung cancer? Yes
Original language	French
Pages (from-to)	S93-S95
Journal	Bulletin du Cancer
Volume	102
Issue number	6
DOIs	https://doi.org/10.1016/s0007-4551(15)31224-8
Publication status	Published - 1 Jun 2015
Externally published	Yes

Access to Document

10.1016/s0007-4551(15)31224-8

Cite this

@article{8be8b1767f76406faefdffa232cd9925,

title = "Reste-t-il une place pour la chimioth{\'e}rapie dans les cancers pulmonaires porteurs d'une alt{\'e}ration mol{\'e}culaire addictive? Les arguments du oui",

abstract = "With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments for the use of cytotoxics in presence of a targetable alteration.",

keywords = "Chemotherapy, Lung cancer, Molecular targeted therapies",

author = "Benjamin Besse",

note = "Publisher Copyright: {\textcopyright} 2015 Soci{\'e}t{\'e} Fran{\c c}aise du Cancer. Publi{\'e} par Elsevier Masson SAS.",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/s0007-4551(15)31224-8",

language = "Fran{\c c}ais",

volume = "102",

pages = "S93--S95",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "6",

}

TY - JOUR

T1 - Reste-t-il une place pour la chimiothérapie dans les cancers pulmonaires porteurs d'une altération moléculaire addictive? Les arguments du oui

AU - Besse, Benjamin

PY - 2015/6/1

Y1 - 2015/6/1

N2 - With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments for the use of cytotoxics in presence of a targetable alteration.

AB - With the emergence of molecular targeted therapies in the management of non-small cell lung cancer, the role of conventional chemotherapy can be questioned. This article presents the key arguments for the use of cytotoxics in presence of a targetable alteration.

KW - Chemotherapy

KW - Lung cancer

KW - Molecular targeted therapies

UR - http://www.scopus.com/inward/record.url?scp=84938084769&partnerID=8YFLogxK

U2 - 10.1016/s0007-4551(15)31224-8

DO - 10.1016/s0007-4551(15)31224-8

M3 - Article

C2 - 26118884

AN - SCOPUS:84938084769

SN - 0007-4551

VL - 102

SP - S93-S95

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 6

ER -

Reste-t-il une place pour la chimiothérapie dans les cancers pulmonaires porteurs d'une altération moléculaire addictive? Les arguments du oui

Abstract

Access to Document

Other files and links

Cite this